Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma

Johns Hopkins University125 enrolled

Overview

The objective of this study is to investigate the utility of 99mTc-sestamibi SPECT/CT imaging for the diagnosis of renal oncocytomas.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

125

Conditions

Clinical T1 Renal Mass

Interventions

Preoperative 99mTc-Sestamibi SPECT/CTOTHER

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Presence of a solid enhancing cT1 renal mass detected on cross-sectional imaging * Scheduled to undergo surgery with either partial or radical nephrectomy * Age ≥18 years Exclusion Criteria: * Pregnancy * Evidence of nodal or distant metastases * History of other malignancy with concern for renal metastasis * Known allergy to technetium or sestamibi

Locations (1)

Johns Hopkins Hospital

Baltimore, Maryland, United States

Outcomes

Primary Outcomes

Correlation of preoperative 99mTc-sestamibi SPECT/CT findings with tumor histology following surgical resection.

Time frame: Within 2 weeks of surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.